Clinical Trial Update: Cetuximab (Erbitux®), Capecitabine and Radiotherapy in Neoadjuvant Treatment of Patients With Rectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating cetuximab with capecitabine and radiotherapy as neoadjuvant treatment for rectal cancer; the current status of the trial is un…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Cancer

Drugs mentioned

• ERBITUX (cetuximab)
• Xeloda (capecitabine)

Snippet

Sponsor: Institute of Oncology Ljubljana | Conditions: Rectal Cancer | Phase 2 | Status: UNKNOWN